Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myasthenia Gravis | 4 | 2018 | 14 | 1.500 |
Why?
|
| Muscle Weakness | 2 | 2018 | 37 | 0.740 |
Why?
|
| Myositis | 1 | 2018 | 10 | 0.660 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 72 | 0.620 |
Why?
|
| Myotonic Dystrophy | 3 | 2020 | 4 | 0.440 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2012 | 6 | 0.430 |
Why?
|
| Neoplasms | 1 | 2018 | 692 | 0.400 |
Why?
|
| Rejuvenation | 1 | 2011 | 2 | 0.390 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2011 | 3 | 0.390 |
Why?
|
| Hand | 1 | 2011 | 66 | 0.380 |
Why?
|
| Thyrotoxicosis | 1 | 2010 | 1 | 0.370 |
Why?
|
| Hypokalemic Periodic Paralysis | 1 | 2010 | 1 | 0.370 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2010 | 9 | 0.370 |
Why?
|
| Sodium Channels | 1 | 2010 | 14 | 0.370 |
Why?
|
| Muscle, Skeletal | 4 | 2018 | 517 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2020 | 1831 | 0.200 |
Why?
|
| Electrodiagnosis | 2 | 2018 | 42 | 0.200 |
Why?
|
| Humans | 14 | 2020 | 32020 | 0.190 |
Why?
|
| Male | 10 | 2020 | 19193 | 0.190 |
Why?
|
| Mexiletine | 1 | 2020 | 1 | 0.190 |
Why?
|
| Hand Strength | 1 | 2020 | 101 | 0.180 |
Why?
|
| Creatine Kinase | 2 | 2017 | 11 | 0.180 |
Why?
|
| Cortactin | 1 | 2018 | 1 | 0.170 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 18 | 0.160 |
Why?
|
| Receptors, Cholinergic | 1 | 2018 | 22 | 0.160 |
Why?
|
| Paralyses, Familial Periodic | 1 | 2018 | 1 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2018 | 49 | 0.160 |
Why?
|
| Bayes Theorem | 1 | 2018 | 80 | 0.160 |
Why?
|
| Exercise Test | 1 | 2018 | 227 | 0.150 |
Why?
|
| Arthrogryposis | 1 | 2016 | 2 | 0.140 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2016 | 2 | 0.140 |
Why?
|
| Muscle Cramp | 1 | 2016 | 3 | 0.140 |
Why?
|
| Neural Conduction | 1 | 2016 | 91 | 0.140 |
Why?
|
| Muscle Strength | 2 | 2015 | 161 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 899 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2013 | 30 | 0.120 |
Why?
|
| Female | 8 | 2020 | 19950 | 0.110 |
Why?
|
| Orphan Drug Production | 1 | 2012 | 1 | 0.110 |
Why?
|
| Paresthesia | 1 | 2012 | 9 | 0.110 |
Why?
|
| Spinal Nerve Roots | 1 | 2012 | 14 | 0.110 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 27 | 0.110 |
Why?
|
| Quality of Life | 1 | 2018 | 928 | 0.110 |
Why?
|
| Axons | 1 | 2012 | 35 | 0.110 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 24 | 0.110 |
Why?
|
| Adult | 6 | 2020 | 9363 | 0.110 |
Why?
|
| Brachial Plexus | 1 | 2012 | 26 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 39 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 36 | 0.100 |
Why?
|
| Biopsy | 1 | 2012 | 260 | 0.100 |
Why?
|
| Microelectrodes | 1 | 2010 | 16 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2010 | 30 | 0.090 |
Why?
|
| Electrophysiology | 1 | 2010 | 71 | 0.090 |
Why?
|
| Potassium | 1 | 2010 | 39 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2010 | 81 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3523 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2010 | 96 | 0.090 |
Why?
|
| Family | 1 | 2010 | 117 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2010 | 109 | 0.090 |
Why?
|
| Action Potentials | 1 | 2010 | 178 | 0.090 |
Why?
|
| Middle Aged | 5 | 2020 | 11866 | 0.090 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2009 | 2 | 0.080 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 2 | 0.080 |
Why?
|
| DNA | 1 | 2010 | 228 | 0.080 |
Why?
|
| Insulin | 1 | 2010 | 366 | 0.080 |
Why?
|
| Oculomotor Muscles | 1 | 2006 | 5 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1324 | 0.070 |
Why?
|
| Young Adult | 3 | 2015 | 2613 | 0.050 |
Why?
|
| Adolescent | 3 | 2016 | 3523 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2020 | 525 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2018 | 8 | 0.040 |
Why?
|
| Electromyography | 1 | 2018 | 59 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 167 | 0.040 |
Why?
|
| Aged | 3 | 2017 | 10338 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2015 | 28 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 632 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 108 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2015 | 143 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 639 | 0.030 |
Why?
|
| Myotonic Disorders | 1 | 2013 | 3 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 30 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 68 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 147 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 261 | 0.030 |
Why?
|
| alpha-Glucosidases | 1 | 2012 | 3 | 0.030 |
Why?
|
| Tetrabenazine | 1 | 2012 | 3 | 0.030 |
Why?
|
| Spasms, Infantile | 1 | 2012 | 4 | 0.030 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2012 | 5 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2012 | 19 | 0.030 |
Why?
|
| Drug Approval | 1 | 2012 | 10 | 0.030 |
Why?
|
| Health Care Sector | 1 | 2012 | 18 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2013 | 444 | 0.030 |
Why?
|
| United States | 2 | 2012 | 3938 | 0.030 |
Why?
|
| Biological Products | 1 | 2012 | 77 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1017 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1061 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 42 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2009 | 68 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2009 | 75 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 2475 | 0.020 |
Why?
|
| Child | 1 | 2012 | 2440 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 785 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 7466 | 0.010 |
Why?
|